Lotus Pharmaceutical Co., Ltd. announced Name of the previous position holder: Arni Hardarson, Resume of the previous position holder: Representative Director of Lotus Pharmaceutical Co., Ltd. Name of the new position holder: Nat Ativitavas, Resume of the new position holder: Director of Innobic (Asia) Company Limited. Reason for the change: Alvogen Emerging Markets Holdings Limited assigned a new representative director. Effective date of the new appointment: 2023/09/04.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
287 TWD | +2.14% | +1.77% | +5.51% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.51% | 2.36B | |
+32.36% | 694B | |
+30.01% | 593B | |
-1.60% | 371B | |
+20.07% | 331B | |
+6.04% | 290B | |
+14.49% | 239B | |
-3.31% | 209B | |
+10.07% | 209B | |
+9.27% | 169B |
- Stock Market
- Equities
- 1795 Stock
- News Lotus Pharmaceutical Co., Ltd.
- Lotus Pharmaceutical Co., Ltd. Announces Director Changes